Cell proliferation measured by MIB1 and timing of surgery for breast cancer

British Journal of Cancer

Volumn 77, Issue 9, 1998, Pages 1502-1507

  Cooper, L S ^a   Gillett, C E ^a   Smith, P ^a   Fentiman, I S ^a   Barnes, D M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Menstrual cycle; MIB1; Proliferative activity; Timing of surgery

Indexed keywords

CANCER ANTIBODY; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; STAINING;

EID: 0031895578     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.247     Document Type: Article

References (32)

1. Anderson TJ, Ferguson DJP and Raah GM (1981) Cell turnover in the 'resting' breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 46; 376-382
2. Anon (1997) News. J Natl Cancer Inst 89: 473-475
3. Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Rubens RD and Fentiman IS (1991a) Timing of surgery during menstrual cycle and survival of pre-menopausal women with operable cancer. Lancet 337: 1261-1264
4. Badwe RA, Gregory WM, Richards MA, Fentiman IS, Saad Z, Chaudary MA, Bentley AE and Rubens RD (1991b) Surgical procedures, menstrual cycle phase and prognosis in operable breast cancer. Lancet 338: 815-816
5. Badwe RA, Bettelheim R, Millis RR, Gregory W, Richards MA and Fentiman IS (1995) Cyclical tumour variations in pre-menopausal women with early breast cancer. Eur J Cancer 31: 2181-2184
6. Bankfalvi A (1994) Wet autoclave pre-treatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 74: 223-228
7. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J and Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin fixed paraffin sections. J Pathol 169: 357-363
8. Cox DR (1972) Regression models and life tables. JR Stat Soc 34: 187-220
9. Ellis PA, Makris A, Burton SA, Titley J, Ormerod MG, Salter J, Powles TJ, Smith IE and Dowsett, M (1996) Comparison of MIB1 proliferation index with S-phase fraction in human breast carcinomas. Br J Cancer 73: 640-643
10. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer; experience from a large study with long term follow up. Histopathology 19: 403-410
11. Fentiman IS, Gregory WM and Richards MA (1994) Effect of menstrual phase on surgical treatment of breast cancer. Lancet 334: 402
12. Ferguson DJP and Anderson TJ (1981) Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181
13. Gerdes J, Schwab U, Lemke H and Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20
14. Hawkins RA (1985) Receptors in the management of breast cancer. Br J Hosp Med Sept: 160-164
15. Hrushesky WJM, Bluming AZ, Gruber SA and Southern RB (1989) Menstrual influence on surgical cure of breast cancer. Lancet 338: 949-953
16. Lipponen ME, Papinaho S, Eskelinen M, Klemi PJ, Aaltomaa S, Kosma VM, Marin S and Syrjanen K (1992) DNA ploidy, S phase fraction and mitotic indices as prognostic predictors of female breast cancer. Anticancer Res 12: 1533-1538
17. McCormick D, Chong H, Hobbs C, Datta C and Hall PA (1993) Detection of the Ki67 antigen in fixed and wax embedded sections with the monoclonal antibody MIB1. Histopathology 22: 355-360
18. Neubauer A and Hunn D (1987) Monoclonal antibody Ki67 as a proliferation marker. Br J Haematol 55: 495
19. Norton AJ, Jordan S and Yeomans P (1994) Brief high temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173: 371-379
20. Oliver DJ and Ingram DM (1995) Timing of surgery during menstrual cycle for breast cancer: possible role of growth factors. Eur J Cancer 31: 325-328
21. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Rubens RD and Richards MA (1990) DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 61: 671-674
22. Perren TJ (1995) The timing of breast cancer surgery with respect to the menstrual cycle. More data which emphasise the need for a prospective study. Breast 4: 1-3
23. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG (1977) Design and analysis of clinical trials requiring prolonged observation of each patient II: analysis and examples. Br J Cancer 35: 1-39
24. Pinder SE, Wencyk P, Sibbeing DM, Bell JA, Elston CW, Nicholson R, Robertson JFR, Blarney RW and Ellis IO (1995) Assessment of the new proliferative marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 72: 146-149
25. Stonelake PS, Powell J, Dunn JA, Bramhall SR, Neoptolemos PR, Baker PR and Morrison JM (1995) Influence of timing of surgery during menstrual cycle on survival of premenopausal women with operable breast cancer. Breast 4: 19-24
26. van Dierendonk JH, Keijezer R, van de Velde CJH and Cornelisse CJ (1989) Nuclear distribution of the Ki67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 49: 2999-3006
27. Veronese SM, Maisano C and Scibilia J (1996) Comparative prognostic value of Ki67 and MIB1 proliferation indices in breast cancer. Anticancer Res 16: 2717-2722
28. von Minckwitz G, Kaufmann M, Dobberstein S, Grischke EM and Diel IJ (1995) Surgical procedure can explain varying influence of menstrual cycle on prognosis of pre-menopausal breast cancer patients. Breast 4: 29-32
29. Walker RA and Camplejohn RS (1988) Comparison of monoclonal antibody Ki67 reactivity with grade and DNA flow cytometry of breast cancer. J Cancer 51: 281-283
30. Weidner N, Morden DH and Vartanian R (1994) Correlation of Ki67 antigen expression with mitotic figure index and tumour grade in breast carcinomas using the novel 'paraffin' reactive MIB1 antibody. Hum Pathol 25: 337-342
31. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U and von Kleist S (1991) Ki67 immunostaining in human tumours and its relationship to prognosis. Cancer 67: 421-428
32. World Health Organization (1982) Histological typing of breast tumours. Tumori 68: 181-198